Evidence map›Paper›PMID 40766085›Full record

ArticleFrontiers in microbiology2025

Epidemiology risk factors and antifungal resistance patterns of

Hazrat Bilal, Xiaohui Li, Xunsong Wang, Muhammad Nadeem Khan, Muhammad Shafiq, Jiamei Yu, Hanman Qiu, Qiao-Li Lv, Bin Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hazrat BilalJiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumor Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Xiaohui LiJiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumor Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Xunsong WangDepartment of Medical Laboratory, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, Jiangxi, China.
Muhammad Nadeem KhanDepartment of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
Muhammad ShafiqDepartment of Pharmacology, Research Institute of Clinical Pharmacy, Shantou University Medical College, Shantou, China.
Jiamei YuJiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumor Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Hanman QiuJiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumor Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Qiao-Li LvJiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumor Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Bin XuJiangxi Key Laboratory of Oncology (2024SSY06041), JXHC Key Laboratory of Tumor Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Candidiasis in cancer patients remains largely unexplored in China. This study examines risk factors and antifungal susceptibility patterns of Methods: Clinical and demographic data on Results: Among 2,761 Conclusion: These findings may aid healthcare officials in improving

Indexed as

antifungal consumptionantifungal resistancecancer patientsCandida speciesepidemiology and risk factors

Identifiers

PMID40766085
PMCPMC12321901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.